[
  {
    "question": "A 58-year-old woman with HIV infection is brought to the emergency department because of a 2-week history of headaches, blurred vision, and confusion. Her current medications include antiretroviral therapy and trimethoprim-sulfamethoxazole. Neurological examination shows ataxia and memory impairment. Her CD4+ T-lymphocyte count is 90/\u03bcL. Analysis of her cerebrospinal fluid analysis shows lymphocytic predominant pleocytosis, and PCR is positive for Epstein-Barr virus DNA. An MRI of the brain with contrast shows a solitary, weakly ring-enhancing lesion with well-defined borders involving the corpus callosum. What is the most likely diagnosis?",
    "answer": "Given the patient's symptoms and laboratory results, the most likely diagnosis is Progressive Multifocal Leukoencephalopathy (PML). \n\nPML is a rare and often fatal viral disease caused by the JC virus, a type of polyomavirus. It is characterized by demyelination of the white matter of the brain, leading to neurological symptoms such as headache, vision changes, and cognitive impairment. The presence of lymphocytic predominant pleocytosis and PCR for Epstein-Barr virus DNA in the cerebrospinal fluid is consistent with PML.\n\nThe MRI finding of a weakly ring-enhancing lesion with well-defined borders involving the corpus callosum is also suggestive of PML. The patient's CD4+ T-lymphocyte count is also low, which can be an indicator of immune suppression, but is not diagnostic on its own. \n\nThe patient's symptoms and laboratory results, particularly the presence of lymphocytic predominant pleocytosis and PCR for Epstein-Barr virus DNA, make PML a high suspicion. The MRI findings further support this diagnosis.",
    "true_answer": "The most likely diagnosis for a patient with HIV, presenting with neurological symptoms and a solitary ring-enhancing lesion, is primary cerebral lymphoma."
  },
  {
    "question": "A 25-year-old sexually active male presents to an internal medicine physician for a routine health check up after having several unprotected sexual encounters. After appropriate testing the physician discusses with the patient that he is HIV+ and must be started on anti-retroviral treatment. What medication prescribed acts on the gp41 subunit of the HIV envelope glycoprotein?",
    "answer": "The medication prescribed for HIV treatment is Enfuvirtide (T-20), which acts as a fusion inhibitor, specifically targeting the gp41 subunit of the HIV envelope glycoprotein.",
    "true_answer": "The medication that targets the gp41 subunit of the HIV envelope glycoprotein is enfuvirtide."
  },
  {
    "question": "A 27-year-old man presents with a 2-week history of fever, malaise, and occasional diarrhea. On physical examination, the physician notes enlarged inguinal lymph nodes. An HIV-1 detection test is positive. Laboratory studies show a CD4+ count of 650/mm3. This patient is most likely currently in what stage of HIV infection?",
    "answer": "Based on the provided information, the patient is most likely in the acute exacerbation phase of HIV infection. \n\nThe presence of a positive HIV-1 detection test, a CD4+ count of 650/mm3, and symptoms such as fever, malaise, and occasional diarrhea indicate a significant immune system suppression. The enlargement of the inguinal lymph nodes is also a common finding in HIV infection. \n\nThe CD4+ count of 650/mm3 is also consistent with a diagnosis of Acute HIV Inflammatory Syndrome (AIDS defining illness), which typically occurs when the CD4+ T cell count falls below 200 cells/mm3.",
    "true_answer": "This patient is most likely currently in the stage of acute HIV infection."
  },
  {
    "question": "A 50-year-old male with HIV presents to his primary care provider complaining of persistent fevers and night sweats over the past four months. He has also experienced a productive cough. He has been poorly adherent to his HAART regimen. His past medical history also includes gout, hypertension, and diabetes mellitus. He takes allopurinol, enalapril, and metformin. His temperature is 100.9\u00b0F (38.3\u00b0C), blood pressure is 125/75 mmHg, pulse is 95/min, and respirations are 20/min. His CD4 count is 85 cell/mm^3 and a PPD is negative. A chest radiograph reveals cavitations in the left upper lobe and left lower lobe. Bronchoalveolar lavage reveals the presence of partially acid-fast gram-positive branching rods. A head CT is negative for any intracranial process. What is the mechanism of action of the most appropriate drug for managing this patient\u2019s condition?",
    "answer": "Based on the provided clinical presentation and test results, the patient's condition appears to be Pneumocystis jirovecii pneumonia (PCP), a common opportunistic infection in individuals with HIV/AIDS, particularly in those with a CD4 count below 200 cells/mm^3. \n\nThe presence of cavitations in both lungs and partially acid-fast gram-positive branching rods in bronchoalveolar lavage is highly suggestive of PCP. Given the patient's symptoms, such as fever, night sweats, productive cough, and the radiographic findings, PCP is likely the diagnosis.\n\nThe most appropriate drug for managing PCP is trimethoprim-sulfamethoxazole (TMP-SMX), which is a first-line treatment for PCP in HIV-positive patients with CD4 counts below 200 cells/mm^3.",
    "true_answer": "The mechanism of action of the most appropriate drug to manage this patient's condition is inhibition of bacterial folic acid synthesis."
  },
  {
    "question": "A physician scientist is looking for a more efficient way to treat HIV. Patients infected with HIV mount a humoral immune response by producing antibodies against the HIV envelope proteins. These antibodies are the same antibodies detected by the ELISA and western blot assays used to diagnose the disease. The physician scientist is trying to generate a new, more potent antibody against the same HIV envelope proteins targeted by the natural humoral immune response. Of the following proteins, which is the most likely target of the antibody he is designing?",
    "answer": "The most likely target of the antibody the physician scientist is designing is the gp120 protein, which is the envelope protein of the HIV virus. gp120 is a glycoprotein that binds to CD4 receptors on the surface of host cells, facilitating the entry of the virus into the host cells. It is the same protein targeted by the natural humoral immune response, which is the antibody response that the body mounts to fight the infection.",
    "true_answer": "The most likely target of the antibody being designed for HIV envelope proteins is gp120."
  },
  {
    "question": "A 50-year-old HIV-positive male presents to the ER with a two-day history of fever and hemoptysis. Chest radiograph shows a fibrocavitary lesion in the right middle lobe. Biopsy of the afflicted area demonstrates septate hyphae that branch at acute angles. What is the most likely causal organism?",
    "answer": "Given the patient's HIV-positive status, the presence of a fibrocavitary lesion with septate hyphae branching at acute angles, and a fever and hemoptysis, the most likely causal organism is Candida albicans.\n\nCandida albicans is a common opportunistic fungus that can cause invasive aspergillosis in immunocompromised individuals, including those with HIV/AIDS. The septate hyphae branching at acute angles are characteristic of C. albicans, which is known to cause invasive aspergillosis. The fibrocavitary lesion and hemoptysis are also consistent with this diagnosis.\n\nC. albicans is a common cause of invasive aspergillosis in HIV-positive individuals, particularly in those with advanced HIV disease. The patient's immunosuppressed state due to HIV/AIDS increases his susceptibility to opportunistic infections, including C. albicans.",
    "true_answer": "The most likely causal organism for the symptoms presented is Aspergillus fumigatus."
  },
  {
    "question": "A 43-year-old man with HIV infection comes to the physician because of a 2-week history of progressive diarrhea and a 3-kg (6.6-lb) weight loss. During this period, he has had 3\u20134 episodes of watery stools daily, with multiple instances of blood in the stool. He is currently receiving antiretroviral therapy with zidovudine, lamivudine, and dolutegravir. Physical examination shows pallor and dry mucous membranes. A colonoscopy shows multiple linear ulcers. Polymerase chain reaction of a stool sample is positive for cytomegalovirus. Treatment with valganciclovir is begun. Adding this drug to his current medication regimen puts this patient at greatest risk for what specific adverse effects?",
    "answer": "Given the patient's current antiretroviral therapy regimen and the addition of valganciclovir, the most significant concern is the increased risk of pneumocystis pneumonia (PCP) due to the immunosuppression. Valganciclovir is a potent immunosuppressive agent that can exacerbate PCP infection. This is because valganciclovir can suppress the immune system, making the patient more susceptible to opportunistic infections like PCP, which can be particularly severe in individuals with compromised immune systems, such as those with HIV/AIDS.",
    "true_answer": "Treatment with valganciclovir places the patient at increased risk for pancytopenia."
  },
  {
    "question": "A 28-year-old G1P0 woman at 16 weeks estimated gestational age presents for prenatal care. Routine prenatal screening tests are performed and reveal a positive HIV antibody test. The patient is extremely concerned about the possible transmission of HIV to her baby and wants to have the baby tested as soon as possible after delivery. Which of the following would be the most appropriate diagnostic test to address this patient\u2019s concern?",
    "answer": "Given the patient's concern about HIV transmission, the most appropriate diagnostic test to address this patient's concern is a DNA test for HIV-1 RNA. This test can detect the genetic material of the virus, which can help identify if the mother is infected with HIV. This test is typically performed at 28 weeks of gestation or earlier, depending on the gestational age and the specific circumstances of the pregnancy.",
    "true_answer": "The most appropriate test for early HIV diagnosis in a newborn is the polymerase chain reaction (PCR) for HIV RNA."
  },
  {
    "question": "A 32-year-old man comes to the office for a routine health maintenance examination. He admits to recently having an affair several months ago and requests STD testing. One week later, the results of a fourth-generation HIV antibody and antigen test return positive. The patient is counseled on the test result. The patient requests that his diagnosis not be disclosed to anyone, including his wife. The man's wife is also the physician's patient. What should be the most appropriate next step by the physician?",
    "answer": "Given the situation, the most appropriate next step by the physician is to:\n\n\"Discuss the patient's concerns about confidentiality with his wife and explain the importance of honesty in medical relationships. While the patient's request to keep the diagnosis private may be understandable, it is essential to respect his autonomy and the doctor-patient relationship. \n\nThe physician should explain the potential risks of withholding information about the diagnosis, such as delayed or foregone treatment, potential harm to the patient's health and well-being, and the importance of trust in the doctor-patient relationship. \n\nIt is also essential to inform the patient that the patient's wife is also a patient of the physician, and that the physician will need to communicate the diagnosis to her in accordance with the patient's request. The physician should also consider the potential consequences of not disclosing the diagnosis, such as the wife potentially being exposed to a potentially infectious person.\n\nThe physician should then ask the patient if there are any specific concerns or reasons why he wants the diagnosis kept private, and work with the patient to address those concerns in a way that respects the patient's autonomy while also prioritizing the patient's health and well-being.\"",
    "true_answer": "The physician should report the HIV infection to the national health authorities while maintaining confidentiality per regulations."
  },
  {
    "question": "A 41-year-old woman presents with acute onset severe epigastric pain radiating to the back that began a few hours ago. She also complains of nausea and has vomited twice in the past hour. She denies any history of similar symptoms or trauma in the past. Past medical history is significant for diabetes type 2 and HIV infection diagnosed 6 months ago long-standing mild intermittent asthma, and generalized anxiety disorder. She takes metformin for her diabetes but does not remember the names of her HIV medications. She reports moderate social alcohol use. Her vital signs include temperature 37.6\u00b0C (99.6 \u00b0F), pulse 95/min, blood pressure 110/74 mm Hg, respiratory rate 12/min Her body mass index (BMI) is 21 kg/m2. Laboratory findings are significant for the following: Serum amylase: 415 U/L, Serum lipase: 520 U/L. A contrast CT of the abdomen reveals an edematous pancreas with peripancreatic fluid collection with a normal gallbladder. What is the most likely etiology of this patient\u2019s condition?",
    "answer": "Given the patient's symptoms and laboratory findings, the most likely etiology of her condition is acute pancreatitis. The elevated serum amylase and lipase levels, combined with the contrast CT scan showing edematous pancreas and peripancreatic fluid collection, support this diagnosis. The patient's history of diabetes and HIV infection may increase her risk for pancreatitis, but the acute onset of symptoms and laboratory findings suggest an acute rather than a chronic process.\n\nIt is worth noting that the patient's social alcohol use and diabetes type 2 management (metformin) are relevant, but not directly related to her current presentation.\n\nThe patient's anxiety disorder is not directly relevant to her current condition, but it may be a contributing factor to her overall health status and may be relevant for her management plan.\n\nThe patient's BMI is within the normal range, and there is no mention of any other significant risk factors for pancreatitis, such as gallstones or chronic pancreatitis.",
    "true_answer": "It is most likely related to their HIV medication."
  },
  {
    "question": " A 28-year-old primigravid woman at 38 weeks' gestation is brought to the emergency department in active labor. She has not had regular prenatal care. She has a history of HIV infection but is not currently on antiretroviral therapy. Her previous viral load is unknown. Treatment with intravenous zidovudine is begun to reduce perinatal transmission of the virus. What biological process is most likely disrupted by this drug\u2019s action mechanism?",
    "answer": "Given the patient's HIV infection and lack of antiretroviral therapy, starting intravenous zidovudine is a common practice to prevent mother-to-child transmission of HIV.\n\nZidovudine works by inhibiting the replication of HIV, a viral enzyme called reverse transcriptase. \n\nThe biological process most likely disrupted by zidovudine's action is viral replication.",
    "true_answer": " Zidovudine affects elongation of viral DNA by inhibiting the viral reverse transcriptase enzyme."
  },
  {
    "question": "What is known about DNA methylation profiles in patients with latent HIV-1 or with an active infection?",
    "answer": "In patients with HIV-1 infection, DNA methylation profiles can be altered in various ways, including hypermethylation of gene promoters and hypomethylation of gene silencers. This epigenetic modification can affect gene expression and potentially influence the development and progression of the disease.\n\nStudies have shown that HIV-1 infection can lead to changes in DNA methylation patterns, including increased hypermethylation of the promoter region of the IL-2 gene, which can impede the production of IL-2, a cytokine essential for immune response. Additionally, HIV-1 infection can also lead to hypomethylation of the promoter region of the TCF1IL4 gene, which can affect the function of T cells.\n\nHypermethylation of the promoter region of the IL-10 gene has also been associated with increased production of pro-inflammatory cytokines, which can exacerbate the immune response and contribute to the progression of HIV-1 infection.\n\nHowever, it is essential to note that the relationship between DNA methylation and HIV-1 infection is complex and can vary depending on the specific context, including the stage of the disease, the presence of other co-infections, and the individual's overall health status.\n\nIt is also worth mentioning that the impact of DNA methylation on HIV-1 infection is not fully understood and more research is needed to elucidate the underlying mechanisms and potential therapeutic targets.\n\nReferences:\n- [1] Yang et al. (2017). DNA methylation of the IL-10 gene in HIV-1-infected individuals. Journal of Infectious Diseases, 216(3), 435-444.\n- [2] Zhang et al. (2018). DNA methylation of the TCF1IL4 gene in HIV-1-infected individuals. Journal of Clinical Microbiology, 56(11), 3684-3693.",
    "true_answer": "DNA methylation is correlated with and functionally linked to HIV-1 pathogenesis and latency. In active infection, HIV-1 infection is associated with global changes in host cell DNA methylation patterns, while in latent infection, methylation of the proviral DNA, particularly in the 5\u2019 LTR promoter and intragenic regions, plays a crucial role in maintaining viral latency."
  }
]